Side-group chemical gating via reversible optical and electric control in a single molecule transistor

Uncovering the inherent isomerization mechanism of azobenzene driven by an electric field on the platform of graphene-molecule-graphene single molecule junctions.
Side-group chemical gating via reversible optical and electric control in a single molecule transistor

Azobenzene-derivatives have been widely studied for their reversible isomerization between trans and cis forms under the irradiation of visible (Vis) and ultraviolet (UV) lights, where the trans form is nearly planar while the cis isomer adopts a bent conformation out of the plane. Single-molecule junctions provide a platform to explore the inherent physical characteristics at the atomic scale by tracing the junction conductance in real time, which are inaccessible in bulky materials. After sandwiched on nanogapped electrodes, its isomerization process of azobenzene can be traced in real time by reading the junction conductance. Based on single-molecule junctions, previous works suggested that other than external light stimuli, resonant or inelastic tunneling of electrons or the electric field could trigger the isomerization of azobenzene as well.

In this work, individual 2′-p-tolyldiazenyl-1,1′:4,4′-terphenyl-4,4″-dicarboxylic acid (TTDA) molecules, which contain an azobenzene sidegroup as the molecular bridge, were immobilised on nanogapped graphene electrodes to create graphene-molecule-graphene single molecule junctions. Surprisingly, we achieved the reversible switching between two states driven by photon and electric field. In addition, the combined experiment and calculated results consistently revealed the mechanism of the isomerization process driven by an electric field. Due to the opposite directions of the projected dipole moments along the terphenyl backbone for trans and cis forms, the additional energy caused by electric field of the two conformations are different. Ultimately, the electric field could tune either of the two conformations as the stable state by adjusting the energy alignment between trans and cis forms.

Except the stable states, the energy barriers for the two dynamic processes as a function of the bias voltages were carried out experimentally. The modulated energy barrier can be explained with the transition state in the same way that electric field can adjust the energy of the transition state to raise or lower the energy barrier.

Furthermore, we also realised a single-molecule memoriser by using a large bias to write (fix the molecule as trans or cis forms) and a small bias (0.01 V) to read out the states. It was worth mentioning that the structure of azobenzene can be stabilised (either cis or trans) for long-term measurements under a small bias. For more details please see our article in Nature Communications 10, 1450 (2019):

This material is provided by Linan Meng, Na Xin and Xuefeng Guo.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Go to the profile of Ruth Milne
almost 5 years ago

So glad to see your behind the paper on the community! 

Subscribe to the Topic

Electrical and Electronic Engineering
Technology and Engineering > Electrical and Electronic Engineering

Related Collections

With collections, you can get published faster and increase your visibility.

Pre-clinical drug discovery

We welcome studies reporting advances in the discovery, characterization and application of compounds active on biologically or industrially relevant targets. Examples include emerging screening technologies, the development of small bioactive compounds/peptides/proteins, and the elucidation of compound structure-activity relationships, target interactions and mechanism-of-action.

Publishing Model: Open Access

Deadline: Mar 31, 2024

Biomedical applications for nanotechnologies

Overall, there are still several challenges on the path to the clinical translation of nanomedicines, and we aim to bridge this gap by inviting submissions of articles that demonstrate the translational potential of nanomedicines with promising pre-clinical data.

Publishing Model: Open Access

Deadline: Dec 31, 2023